Emergent BioSolutions Inc. said Wednesday that it signed a three-year contract with the federal government worth up to $448 million to supply anthrax vaccine for the nation's biodefense stockpile. (BioWorld Today)
Emergent BioSolutions Inc. said Wednesday that it signed a three-year contract with the federal government worth up to $448 million to supply anthrax vaccine for the nation's biodefense stockpile. (BioWorld Today)
The Centers for Medicare & Medicaid Services (CMS) has told a physician group that more evidence is needed before the agency could reconsider its July decision that limits payments for drugs used to treat anemia in cancer patients. (BioWorld Today)
The Centers for Medicare & Medicaid Services (CMS) has told a physician group that more evidence is needed before the agency could reconsider its July decision that limits payments for drugs used to treat anemia in cancer patients. (BioWorld Today)
